NovaThera’s Strategy

Novathera’s intellectual property spans the regenerative medicine space from biomaterials technology, through bioprocessing to achieve scale up of cellular production and, into cellular biology to enable careful, controlled production of specific cell types. NovaThera aims to build and commercialise its regenerative medicine technologies from the ground up, starting with the most straight forward applications and gradually increasing the complexity as the science catches up with medical needs.

• To provide technologies (biomaterials, biophotonics, bioreactors, cellular constructs) to facilitate the development of regenerative medicine products; and,

• To develop selected applications as products in regenerative medicine.

NovaThera’s vision is to be an international leader in identifying and developing the platform technologies and intellectual property which will underpin the development of regenerative therapies.